Breast Reconstruction Surgery and Treatment Market
Number of pages: 100 | Report Format: PDF | Published date: May 15, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 577.2 million |
|
Revenue Forecast in 2031 |
US$ 1052.3 million |
|
CAGR |
6.9% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product, Procedure, Surgery, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global breast reconstruction surgery and treatment market was valued at US$ 577.2 million in 2022 and is expected to register a revenue CAGR of 6.9% to reach US$ 1052.3 million in 2023.
Breast Reconstruction Surgery and Treatment Market Fundamentals
Breast reconstruction surgery is a surgical procedure performed to rebuild the shape of the breast after a mastectomy or lumpectomy. This surgery can help to improve the physical appearance of the breast and restore a sense of self-confidence for breast cancer survivors. The choice of breast reconstruction surgery and treatment options may depend on factors such as the patient's age, health status, and personal preferences. Recent trends in breast reconstruction surgery and treatment include increased use of autologous tissue reconstruction, which involves using the patient's own tissue to rebuild the breast. This technique is becoming more popular due to its natural-looking results and lower risk of complications than breast implants. Additionally, advances in 3D printing technology are being used to create custom implants and reconstructive devices, allowing for more personalized and precise treatment. Another trend is the use of nipple-sparing mastectomy techniques, which can preserve the natural appearance of the breast and improve patient satisfaction with their results. These trends demonstrate a continued focus on improving the quality and aesthetics of breast reconstruction surgery and treatment.
The global breast reconstruction surgery and treatment industry analysis report comprehensively analyzes the market, with the factors that either aid or impede the market growth, such as its drivers, restraints, and opportunities. The research provides insight into the companies that operate in the breast reconstruction surgery and treatment market and their efforts to position themselves as key players through expansion strategies and innovations. It also highlights recent developments that contribute to breast reconstruction surgery and treatment market growth. The research also analyzes the impact of the COVID-19 pandemic.
This research is valuable for businesses seeking insights into the market, customers, and competition. The research provides special insights into the segmentation, regions, market size & projection, revenue CAGRs, and other vital information that may help clients make the right decisions. The report assembles data from market players and professionals across the industrial value chain. The study also incorporates qualitative and quantitative assessments from industry professionals. Secondary research, surveys and interviews, and statistical modeling are all used in our research to estimate market size and projection. Our reports deliver the most reliable market data because of our specialized research methods.
[56756]
Breast Reconstruction Surgery and Treatment Market Dynamics
Global breast cancer incidence is rising, and people are becoming more aware of the choices for reconstructive surgery, driving the market for breast reconstruction surgery and treatments. According to WHO, in 2020, 685 000 people worldwide died, and 2.3 million women were diagnosed with breast cancer. The most common cancer globally as of the end of 2020 was breast cancer, diagnosed in 7.8 million women in the previous five years. Additionally, the government's measures to raise breast cancer awareness, enhance patient access to healthcare services, and attractive reimbursement regulations are propelling market expansion. In addition, as more patients choose reconstructive surgery to enhance the appearance of their breasts following cancer treatment, the increased demand for cosmetic surgery and breast augmentation operations is also fueling the market growth. According to the Aesthetic Society report, in 2021, 365,000 breast augmentations were carried out. In addition, 71,000 women had their implants removed but not replaced, whereas 148,000 women had them removed and replaced (+32% from 2020).
Breast Reconstruction Surgery and Treatment Market Ecosystem
This report provides the global breast reconstruction surgery and treatment market analysis in terms of revenue, market growth, market dynamics, regional landscape, and overall competitive positioning of the major market players. The global breast reconstruction surgery and treatment market overview is analyzed from the following perspectives,
Breast Reconstruction Surgery and Treatment Market, By Product
Breast Reconstruction Surgery and Treatment Market, By Procedure
Breast Reconstruction Surgery and Treatment Market, By Surgery
Breast Reconstruction Surgery and Treatment Market, By End User
Breast Reconstruction Surgery and Treatment Market By Product
[87656]
Based on the product, the breast reconstruction surgery and treatment market is segmented into the implant, tissue expander, and acellular dermal matrix. The implant segment is sub-segmented into silicone breast implants, and saline breast implants. Also, the tissue expander is sub-segmented into a saline expander and air tissue expander.
The implant segment accounted for the largest revenue share of the global market in terms of breast reconstruction surgery and treatment market forecast. According to the National Institute of Health, current estimates of the number of women in North America with breast implants range from one to two million, representing 1% of the adult female population. Compared to autologous tissue repair, which requires more extensive surgery and a longer recovery period, breast implants are a comparatively rapid and less invasive choice for breast reconstruction. Additionally, breast implants can be tailored to the patient's desires and produce symmetrical and natural outcomes. Additionally, breast implants are widely accessible and preferred by many patients since they can eliminate the need for subsequent surgeries to remove tissue from other body areas. As a result, the implant market segment has continued to represent a sizeable market share and remains the most widely used option for breast reconstruction surgery and therapy.
The market segmentation sections provide the breast reconstruction surgery and treatment market outlook in terms of the demarcation of different consumer groups. Market segmentation is the splitting of an industry into subgroups depending on characteristics such as product, procedure, surgery, and end user. Market segmentation data helps organizations understand the preferences and distinctive demands of different customer groups and implement targeted marketing strategies. This data additionally helps in identifying potential breast reconstruction surgery and treatment market demand opportunities.
Breast Reconstruction Surgery and Treatment Market By Region
The breast reconstruction surgery and treatment market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
According to the breast reconstruction surgery and treatment industry analysis, North America accounted for the largest revenue share of ~38% of the global breast reconstruction surgery and treatment market share in 2022. There is a high need for reconstructive surgery in the area due to the significant population of breast cancer survivors. According to CDC, about 264,000 women and 2,400 men are diagnosed with breast cancer each year in the U.S., with deaths in 500 men and 42,000 women. Also, as stated by University of Utah Health data, over 300,000 breast implant procedures are carried out annually in the United States. Furthermore, the developed healthcare system in North America makes it simple to get breast reconstruction surgeries. The market has also expanded due to advantageous reimbursement rules and the presence of top pharmaceutical and medical device businesses in the area.
Based on the regions, the global breast reconstruction surgery and treatment market is segmented into:
The industry's regional segmentation provides insights into geographic pockets in terms of breast reconstruction surgery and treatment industry trends, market size, share, and growth rate. This information helps organizations assess potential growth opportunities in new regional markets, understand competitive threats, and develop localized sales and expansion strategies. This section also offers deeper insights into the regional and country-level breast reconstruction surgery and treatment market overview.
Key Components of the Report
Breast Reconstruction Surgery and Treatment Market Competitive Landscape
The market competitive landscape analysis is performed by gathering and evaluating data about the key competitors, industry trends, and market dynamics. It involves collecting and analyzing data on factors such as products, pricing, geographic reach, customer demographics, marketing tactics, and recent developments. Competitive landscape analysis can help organizations identify present or prospective opportunities and risks in the market.
Breast Reconstruction Surgery and Treatment Market Strategic Developments
Reasons To Buy This Report
Key Strengths of Our Report
Target Audience to Benefit from this Report.
Breast reconstruction surgery and treatment is a type of surgical procedure that rebuilds the shape of the breast after a mastectomy or lumpectomy and aims to improve the physical appearance of the breast and restore a sense of self-confidence for breast cancer survivors.
North America has the largest breast reconstruction surgery and treatment market size during the forecast period from 2023 to 2031.
The global breast reconstruction surgery and treatment market is expected to grow at a revenue CAGR of 6.9% during the forecast period from 2023 to 2031.
Lack of knowledge about breast reconstruction surgery and treatment and the stringent regulatory landscape are the major challenges hampering the growth of the global breast reconstruction surgery and treatment market.
The major strategies key market players adopt involve strategic partnerships and collaborations to expand their market reach and capabilities.
The increased global prevalence of breast cancer and raising awareness of breast reconstruction surgery and treatment are the most important drivers of the global breast reconstruction surgery and treatment market.
Key players in the global breast reconstruction surgery and treatment market are Allergan Aesthetics (An AbbVie Company), Sientra, POLYTECH Health & Aesthetics GmbH, GC Aesthetics, Sebbim, Establishment Labs S.A.
Breast implants have the highest share in the global breast reconstruction surgery and treatment market.
Increasing technological advancements for new breast reconstruction surgery and treatment is the major opportunity for the breast reconstruction surgery and treatment market.
*Insights on financial performance are subject to the availability of information in the public domain
Recommended Reports